SIROMED PHARMA, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 11,745,000 |
| 821,329 |
| 218,000 |
| 178,000 |
| 12,448 |
| 14.99 |
| 1.52 |
| 1,341,000 |
| 5,526,000 |
| 171,000 |
| 6,696,000 |
| 2023 |
|---|
| 11,011,000 |
| 799,637 |
| 33,000 |
| 5,000 |
| 363 |
| 15.09 |
| 0.05 |
| 1,346,000 |
| 6,104,000 |
| 147,000 |
| 7,303,000 |
| 2024 |
|---|
| 11,422,000 |
| 875,249 |
| 167,000 |
| 126,000 |
| 9,655 |
| 15.74 |
| 1.10 |
| 1,472,000 |
| 5,429,000 |
| 252,000 |
| 6,649,000 |
Register and
explore Okredo data| 2024 |
|---|
| 11,422,000 |
| 875,249 |
| 167,000 |
| 126,000 |
| 9,655 |
| 15.74 |
| 1.10 |
| 1,472,000 |
| 5,429,000 |
| 252,000 |
| 6,649,000 |
Register and
explore Okredo data2024
Turnover (€)
11,422,000 €
4 % *
Sales per employee (€)
875,249 €9 % *
Profit before tax (€)
167,000 €406 % *
Net Profit (€)
126,000 €2,420 % *
Profit per employee (€)
9,655 €2,560 % *
Total profitability (%)
15.74 %4.31 % *
Net profitability (%)
1.10 %2,100.00 % *
Equity (€)
1,472,000 €9 % *
Amounts Payable And Liabilities (€)
5,429,000 €
-11 % *
Non-current Assets (€)
252,000 €
71 % *
CurrentAssets (€)
6,649,000 €-9 % *